Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Grupo Oncológico Gallego.
Recruitment status was  Active, not recruiting
Pivotal S.L.
Information provided by (Responsible Party):
Grupo Oncológico Gallego Identifier:
First received: July 23, 2008
Last updated: March 15, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2015
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)